Global Rabies Immune Globulin Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Rabies Immune Globulin Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Rabies immunoglobulin (RIG) is a medication made up of antibodies against the rabies virus. It is used to prevent rabies following exposure.
Rabies Immune Globulin report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Rabies Immune Globulin market is projected to reach US$ 694.4 million in 2029, increasing from US$ 424 million in 2022, with the CAGR of 7.3% during the period of 2024 to 2029. Demand from Category II Exposure and Category III Exposure are the major drivers for the industry.
The Rabies Immune Globulin market is driven by the critical need to prevent and treat rabies infections effectively. Rabies immune globulin (RIG) is a key component of post-exposure prophylaxis, providing passive immunity against the virus. The increased awareness of rabies' potential severity, particularly in regions with higher prevalence rates, propels market growth. Additionally, the rising number of travelers and potential exposure to rabies in endemic areas contribute to demand. However, challenges include the limited availability of RIG in certain regions and the high cost associated with its production and administration. Ensuring timely access to RIG, especially in remote or resource-constrained areas, and addressing potential allergic reactions or adverse events are ongoing concerns. The market's success depends on the collaboration between healthcare systems and regulatory bodies to ensure sufficient availability, proper distribution, and affordability of rabies immune globulin, ultimately reducing the global burden of this deadly disease.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Rabies Immune Globulin market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
CSL Behring
Grifols
Sanofi
Sichuan Yuanda Shuyang
CNBG
Kamada
CBPO
Shuanglin Bio
Weiguang Bio
Shanghai RAAS
Bharat Serum
VINS
Segment by Type
ERIG
HRIG
Category II Exposure
Category III Exposure
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Rabies Immune Globulin market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Rabies Immune Globulin, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Rabies Immune Globulin industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Rabies Immune Globulin in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Rabies Immune Globulin introduction, etc. Rabies Immune Globulin Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Rabies Immune Globulin market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Rabies Immune Globulin report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Rabies Immune Globulin market is projected to reach US$ 694.4 million in 2029, increasing from US$ 424 million in 2022, with the CAGR of 7.3% during the period of 2024 to 2029. Demand from Category II Exposure and Category III Exposure are the major drivers for the industry.
The Rabies Immune Globulin market is driven by the critical need to prevent and treat rabies infections effectively. Rabies immune globulin (RIG) is a key component of post-exposure prophylaxis, providing passive immunity against the virus. The increased awareness of rabies' potential severity, particularly in regions with higher prevalence rates, propels market growth. Additionally, the rising number of travelers and potential exposure to rabies in endemic areas contribute to demand. However, challenges include the limited availability of RIG in certain regions and the high cost associated with its production and administration. Ensuring timely access to RIG, especially in remote or resource-constrained areas, and addressing potential allergic reactions or adverse events are ongoing concerns. The market's success depends on the collaboration between healthcare systems and regulatory bodies to ensure sufficient availability, proper distribution, and affordability of rabies immune globulin, ultimately reducing the global burden of this deadly disease.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Rabies Immune Globulin market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
CSL Behring
Grifols
Sanofi
Sichuan Yuanda Shuyang
CNBG
Kamada
CBPO
Shuanglin Bio
Weiguang Bio
Shanghai RAAS
Bharat Serum
VINS
Segment by Type
ERIG
HRIG
Segment by Application
Category II Exposure
Category III Exposure
Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Rabies Immune Globulin market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Rabies Immune Globulin, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Rabies Immune Globulin industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Rabies Immune Globulin in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Rabies Immune Globulin introduction, etc. Rabies Immune Globulin Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Rabies Immune Globulin market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices